3,271
Views
23
CrossRef citations to date
0
Altmetric
Commentary

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines

ORCID Icon, & ORCID Icon
Pages 2965-2968 | Received 11 Feb 2021, Accepted 15 Apr 2021, Published online: 05 May 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.